Introduction {#s1}
============

The endocannabinoid system is broadly distributed in the central nervous system (Freund et al., [@B16]; Castillo et al., [@B7]; Kano, [@B26]). This modulatory system is made up of the endocannabinoids (the two main are N-arachidonoylethanolamine or anandamide and 2-arachidonoylglycerol, 2-AG) (Mechoulam et al., [@B36]; Sugiura et al., [@B50]) as well as their biosynthetic and degrading enzymes (Freund et al., [@B16]; Di Marzo et al., [@B13]) and transport systems (Fu et al., [@B17]). Most of the cannabinoid and endocannabinoid effects are mediated by the G protein-coupled CB~1~ and CB~2~ receptors (Di Marzo et al., [@B13]). CB~1~ receptors are also distributed in the periphery, e.g., skeletal muscle, liver, pancreas, and adipose tissue, where they are involved in cellular functions and energy metabolism (Piomelli, [@B42]; Pagotto et al., [@B40]; Silvestri and Di Marzo, [@B48]; Mazier et al., [@B35]). Anatomically, the protein and mRNA expression of CB~1~ and other components of the endocannabinoid system were demonstrated in human and rodent muscular tissue (Cavuoto et al., [@B9]; Esposito et al., [@B15]; Eckardt et al., [@B14]; Lipina et al., [@B30]; Crespillo et al., [@B11]), in particular in the primary myotubes of skeletal muscle and the rectus abdominis as well as in cultured rat muscular cells (Lipina et al., [@B30]). Functionally, CB~1~ signaling in skeletal muscle has a negative effect on the expression of genes regulating oxidation and insulin sensitivity (Cavuoto et al., [@B8]; Hardie, [@B18]), modulates the glucose/pyruvate/lactate pathways, regulates mitochondrial dihydrolipoamide dehydrogenase (Arrabal et al., [@B4]) and controls myoblast differentiation (Iannotti et al., [@B25]). Therefore, the function and dysfunction of the endocannabinoid system in muscle is a great focus of research interest in order to better understand the underlying mechanisms of metabolic disorders.

In the central nervous system (CNS), CB~1~ receptors are localized on the plasma membrane of synaptic terminals, but also in intracellular compartments (Rozenfeld and Devi, [@B45]; Bénard et al., [@B5]; Hebert-Chatelain et al., [@B19],[@B20]). The anatomical localization and functional implication of CB~1~ receptors on mitochondrial membranes (mtCB~1~) of brain cells were demonstrated in our own (Bénard et al., [@B5]; Hebert-Chatelain et al., [@B19],[@B20]) and in other laboratories (Koch et al., [@B29]; Ma et al., [@B33]; see also Morozov et al., [@B37], [@B38]; Hebert-Chatelain et al., [@B19]; Piomelli, [@B43] for methodological discussions). Thus, activation of brain mtCB~1~ receptors reduces mitochondrial respiration and ATP production (Bénard et al., [@B5]; Hebert-Chatelain et al., [@B19],[@B20]). In the hypothalamus, activation of CB~1~ receptors negatively regulates leptin-induced reactive oxygen species formation (Palomba et al., [@B41]) and increases coupled mitochondria respiration that associates with the generation of reactive oxygen species (Koch et al., [@B29]). CB~1~ has also been shown in our laboratories to be present in muscle mitochondria where it regulates mitochondrial oxidative activity (Arrabal et al., [@B4]). However, a detailed anatomical and functional characterization of mtCB~1~ in striated muscles is still pending. The aim of this study was to investigate in detail the distribution and functional role of mtCB~1~ in three different striated muscles.

To investigate this, specific CB~1~ antibodies applied to two skeletal muscles (gastrocnemius and rectus abdominis) and myocardium of wild-type and knock-out mice, were combined with a high resolution pre-embedding immunocytochemical method for electron microscopy, followed by strict quantification. Moreover, the impact of CB~1~ agonism on oxygen consumption (respiration) of muscle purified mitochondria from wild-type and *CB*~*1*~-KO mice was also analyzed.

Materials and methods {#s2}
=====================

Animal treatment
----------------

The procedures were carried out in accordance with European Communities Council Directives (2003/65/CE and 2010/63/UE) and current Spanish regulations (Real Decreto 53/2013 and Ley 32/2007). The protocols for animal care and use were approved by the appropriate Committee at the University of the Basque Country UPV/EHU (CEBA/93/2010/GRANDESMORENO). Furthermore, great efforts were made in order to minimize the number and suffering of the animals used.

6 wild-type C57BL/6N female mice (3--5 month old) and 3 *CB*~*1*~-KO female mice were used. *CB*~*1*~-KO mice were obtained, bred and genotyped as described (Marsicano et al., [@B34]). The line was in a mixed genetic background, with a predominant C57BL/6N contribution. Animals were maintained under standard conditions (12 h light/dark cycle) with food (standard chow, Global Diet 2014S, Harlan) and water *ad libitum*. During the light cycle, mice were deeply anesthetized by intraperitoneal injection of ketamine/xilazine (80/10 mg/kg body weight) and were transcardially perfused at room temperature (RT, 20--25°C) with phosphate-buffered saline (PBS 0.1 M, pH 7.4) for 20 s, followed by the fixative solution made up of 4% formaldehyde (freshly depolymerized from paraformaldehyde), 0.2% picric acid and 0.1% glutaraldehyde in a phosphate buffer (PB 0.1 M, pH 7.4) for 10--15 min. Then, muscles (rectus abdominis, gastrocnemius and myocardium) were removed and postfixed in the fixative solution for approximately 1 week at 4°C. Afterwards, they were stored at 4°C in a 1:10 diluted fixative solution until used.

Preembedding immunogold method for CB~1~ immunoelectron microscopy
------------------------------------------------------------------

Muscular tissues were cut at 50 μm in a vibratome and collected in 0.1 M PB (pH 7.4) at RT. Sections were preincubated in a blocking solution of 10% bovine serum albumin BSA, 0.1% sodium azide and 0.02% saponin prepared in TBS (1X, pH 7.4) for 30 min at RT. A preembedding silver-intensified immunogold method was used for the localization of the CB~1~ protein. Muscular sections were incubated in the primary goat CB~1~ polyclonal antibodies (2 μg/ml; CB1-Go-Af450-1; Frontier Science Co. Ltd; 1-777-12, Shinko-nishi, Ishikari, Hokkaido, Japan) in 10% BSA/TBS containing 0.1% sodium azide and 0.004% saponin on a shaker for 2 days at 4°C.

After several washes in 1% BSA/TBS, tissue sections were incubated in a secondary 1.4 nm gold-labeled rabbit anti-goat IgG (Fab\' fragment, 1:100, Nanoprobes Inc., Yaphank, NY, USA) in 1% BSA/TBS with 0.004% saponin on a shaker for 4 h at RT. Thereafter, the tissue was washed in 1% BSA/TBS, stored overnight at 4°C and postfixed in 1% glutaraldehyde in TBS for 10 min at RT. Following the washes in double-distilled water, gold particles were silver-intensified with a HQ Silver kit (Nanoprobes Inc., Yaphank, NY, USA) for about 12 min in the dark and then washed in 0.1 M PB (pH 7.4). Stained sections were osmicated (1% OsO~4~ in 0.1 M PB, pH 7.4, 20 min), dehydrated in graded alcohols to propylene oxide and plastic-embedded flat in Epon 812. 65 nm ultrathin sections were collected on mesh nickel grids, stained with uranyl acetate and lead citrate, and examined in a Philips EM208S electron microscope. Tissue preparations were photographed by using a digital camera coupled to the electron microscope.

### Semi-quantification of mitochondrial CB~1~ in muscle

Fifty micrometer-thick muscular sections from each animal genotype (*n* = 3 each) were cut at 65 nm and random electron micrographs (10,000--25,000X) were taken from the grids (132 μm side). To avoid false negatives, only ultrathin sections in the first 1.5 μm from the surface of the tissue block were examined. Positive labeling was considered if at least one immunogold particle was over mitochondria or within approximately 30 nm from the mitochondria membrane. Metal particles on mitochondrial membranes were visualized and counted by unbiased observers. The numbers of labeled mitochondria were normalized to the total number of mitochondria in the images in order to establish the proportion of CB~1~-positive mitochondria. Normalized mtCB~1~ labeling versus total CB~1~ defined the proportion of mtCB~1~ versus total CB~1~ as performed previously (Bénard et al., [@B5]; Hebert-Chatelain et al., [@B19]). Density of mitochondrial CB~1~ immunolabeling was calculated as immunoparticles/μm membrane of positive mitochondria. Image-J software (1.43u version, NIH, USA) was used to measure the membrane length and analyzed area. Values within wild-type or *CB*~*1*~-KO littermates did not show any significant difference, allowing the pooling of respective wild-type and *CB*~*1*~-KO littermates.

Mitochondrial isolation from heart and mitochondrial respiration
----------------------------------------------------------------

Mitochondria were isolated from the heart of the mice by differential centrifugation. Hearts were collected in isolation medium I (in mM: 210 mannitol, 70 sucrose, 50 Tris-HCl, pH 7.4, and 10 K-EDTA), finely cut and then digested by trypsin (0.5 mg/g of heart muscle) for 30 min. The proteolysis was stopped by addition of trypsin inhibitor (soybean 3:1 inhibitor to trypsin). Tissues were homogenized using a tissue homogenizer. The homogenate was centrifuged at 1000 g for 5 min. The supernatant was strained through gauze and centrifuged at 7000 g for 10 min. The resulting pellet was resuspended in ice-cold isolation medium II (in mM: 225 mannitol, 75 sucrose, 10 Tris-HCl, pH 7.4, and 0.1 K-EDTA), and a new series of centrifugations (1000 and 7000 g) was performed. The last mitochondrial pellet was resuspended into a minimum volume of isolation medium II to obtain a mitochondrial concentration between 10 and 40 mg/ml.

Mitochondrial oxygen consumption ratio (OCR) was monitored at 37°C. Isolated mitochondria were placed in an oxygraph chamber equipped with a Clark oxygen electrode (Hansatech) containing 1 ml of respiration buffer (75 mM mannitol, 25 mM sucrose, 100 mM KCl, 10 mM Tris phosphate, 10 mM Tris-HCl, pH 7.4, 5 mM EDTA). The final mitochondrial concentration in the chamber was 1 mg/ml. The respiratory states were obtained by adding consecutively to the chamber Pyruvate and Malate at 10 mM final (state 4) and then, ADP at 2 mM (state 3). THC was added directly into the respiratory chamber (final concentration 100 and 200 nM) during state 3. Oxygen concentration in the chamber was recorded over the time and effect of THC on the OCR was measured between 5 and 10 min after the THC addition. Respiration rates were normalized to protein concentration. The respiratory coupling ratio (RCR) was defined as the ratio of state 3 over state 4.

Immunoprecipitation
-------------------

Immunoprecipitation of CB~1~ was performed on the mitochondrial fraction isolated as described above by using the Pierce™ Co-Immunoprecipitation Kit, as per manufacturer\'s instructions. Briefly, the mitochondrial fraction (625 μg of protein) were diluted in IP/lysis buffer and pre-cleared using a control agarose resin to minimize non-specific binding. These lysates were then applied to columns containing 8 μg immobilized anti-CB~1~ (Abcam, ab23703) covalently linked to an amine-active resin and incubated overnight at 4°C. The immunoprecipitate was then eluted, mixed with Laemmli buffer, heated to 37°C for 30 min and analyzed by SDS-PAGE using conventional methods.

RNA isolation and qRT-PCR analysis
----------------------------------

Total RNA was extracted from striated (rectus abdominis) mouse muscle (\~100 mg) by using the Trizol method, as previously described (Arrabal et al., [@B4]). Purified RNA (1 μg) and random hexamers were used to generate first strand cDNA using transcriptor reverse transcriptase. cDNA was used as a template for quantitative real-time PCR. The relative quantification was normalized to the expression of the housekeeping gene *Gapdh* and calculated by using the ΔΔCt method. Primers used for the qRT-PCR reaction were obtained based on TaqMan® Gene Expression Assays (Life Technologies) (Table [1](#T1){ref-type="table"}).

###### 

**Primer references for TaqMan® gene expression assays (ThermoFisher)**.

  **Gene name**   **Assay ID**    **Amplicon length**
  --------------- --------------- ---------------------
  *Actb*          Mm00607939_s1   115
  *Gapdh*         Mm99999915_g1   109
  *Gusb*          Mm01197698_m1   71
  *Eno3*          Mm00468267_m1   54
  *Pkm2*          Mm00834102_gH   182
  *Pdha1*         Mm00468675_m1   74
  *Sdha*          Mm01352366_m1   82
  *Cox4i1*        Mm01250094_m1   116

Actb, β-actin; Cox4i1, cytochrome c oxidase subunit 4 isoform 1, mitocondrial; Eno3, enolase 3, β-muscle; Gapdh, glyceraldehyde 3-phosphate dehydrogenase; Gusb, β-glucuronidase; Pdha1, pyruvate dehydrogenase E1 alpha 1; Pkm2, pyruvate kinase, muscle isozyme; Sdha, succinate dehydrogenase complex, subunit A, flavoprotein variant.

Statistical analysis
--------------------

Results were expressed as mean ± S.E.M. of 3--6 determinations per experimental group. For semi-quantification of mitochondrial CB~1~, group differences were compared by the chi-square test. For density of mitochondrial CB~1~ immunolabeling, group differences were analyzed by the Mann Whitney test. For gene expression, group differences were analyzed by one-tailed Student\'s *t*-test with the Welch correction. A *P*-value below 0.05 was considered statistically significant. Graphs and statistical analyses were performed using GraphPad software 4.0 (GraphPad Software Inc., San Diego, USA). Oxygen consumption measurements: statistics were performed using GraphPad Prism6. Values are means ± S.E.M. Paired *t*-test was used when comparing sequential measurements. One-way ANOVA followed by Sidak multiple comparison test were applied when comparing different groups.

Results {#s3}
=======

Immunolocalization of mitochondrial CB~1~ in muscle
---------------------------------------------------

The subcellular compartmentalization of CB~1~ in three different striated muscle tissues of mice by using a preembedding immunogold method for electron microscopy was studied. The gastrocnemius had CB~1~ immunoparticles along the sarcolemma of the muscle fibers. Only scattered immunoparticles were observed at the limits of the sarcomer as well as in the sarcoplasmic reticulum. However, the greatest accumulation of immunoparticles was in the mitochondria (Figure [1](#F1){ref-type="fig"}). About 26% of the mitochondria in the gastrocnemius were CB~1~ immunopositive (25.77% ± 1.022, *n* = 644) with the majority of gold particles disposed on the outer mitochondrial membrane (Figures [1A](#F1){ref-type="fig"}, [2A](#F2){ref-type="fig"}). Importantly, CB~*1*~ staining was virtually absent in the gastrocnemius of mice lacking CB~1~ (*CB*~1~-KO, Figure [1B](#F1){ref-type="fig"}), since only a few mitochondria (0.37% ± 0.040, *n* = 536) exhibited occasional unspecific background particles (Figure [2A](#F2){ref-type="fig"}).

![**subcellular localization of CB~1~ receptors in mitochondria of striated muscles**. Preembedding silver-intensified immunogold method for electron microscopy. CB~1~ immunoparticles (arrows) are localized in outer mitochondrial (mt) membranes of the gastrocnemius **(A)**, rectus abdominis **(C)** and myocardial **(E)** muscles of *CB*~*1*~-WT mice. No labeling is observed in mitochondria (mt) of *CB*~*1*~-KO muscles **(B,D,F)**. Scale bars: 0.5 μm. All electron micrographs were taken at the same magnification (x 22,000).](fphys-07-00476-g0001){#F1}

![**proportion of CB~1~ immunopositive mitochondria. (A)** Values obtained in the gastrocnemius (25.77 ± 1.02%), rectus abdominis (21.29 ± 0.98%) and myocardium (17.24 ± 1.29%) of 3 different mice. These values are very low in *CB*~*1*~-KO muscles (gastrocnemius: 0.37 ± 0.04%; rectus abdominis: 1.45 ± 0.29%; myocardium: 2.79 ± 0.57%). Numbers between parentheses indicate the number of analyzed profiles. Values mean ± S.E.M. Chi-square test. ^\*\*\*^*P* \< 0.001 as compared to *CB*~*1*~-WT. **(B)** Density of CB~1~ gold particles per area (μm^2^) of the immunopositive mitochondria in gastrocnemius (21.49 ± 2.51%), rectus abdominis (16.25 ± 1.95%) and myocardium (3.30 ± 0.60%) of *CB*~*1*~-WT. ^\*\*\*^*P* \< 0.001. Numbers between parentheses indicate the number of analyzed profiles. Density was negligible in *CB*~*1*~-KO, therefore, it was not taken into account to avoid distorting bias. **(C)** Proportion of CB~1~ immunoparticles in mitochondria of the total CB~1~ labeling in gastrocnemius (60 ± 1.73%), rectus abdominis (55.04 ± 1.15%) and myocardium (78.11 ± 1.16%) drops drastically in *CB*~*1*~-KO muscles.](fphys-07-00476-g0002){#F2}

A similar distribution pattern of CB~1~ immunostaining was observed in the other muscles studied. Thus, in the rectus abdominis (Figures [1C,D](#F1){ref-type="fig"}), the proportion of CB~1~ immunopositive mitochondria was slightly lower than in the gastrocnemius (21.29% ± 0.982, *n* = 584) and the background level was estimated to be below 1.5% in the *CB*~*1*~-KO (1.45% ± 0.289, *n* = 538) (Figure [2A](#F2){ref-type="fig"}). Also, the CB~1~ immunolocalization in the myocardium (Figures [1E,F](#F1){ref-type="fig"}) was predominantly in mitochondria (17.24% ± 1.293, *n* = 522) with a background of \~2.8% in the *CB*~*1*~-KO (2.79% ± 0.571, *n* = 501) (Figure [2A](#F2){ref-type="fig"}). Taken together, the mtCB~1~ labeling seems to be highly specific in the three muscles because the percentage of mitochondria with residual staining was negligible in the same muscles of *CB*~*1*~-KO mice processed simultaneously with *CB*~*1*~-WT muscle tissues. Furthermore, the density of CB~1~ immunolabeling, i.e., the number of gold particles per square micron of labeled mitochondrial membrane, was 21.49 ± 2.51 (*n* = 166) in the gastrocnemius, 16.25 ± 1.95 (*n* = 124) in the rectus abdominis and 3.30 ± 0.60 (*n* = 90) in the myocardium (Figure [2B](#F2){ref-type="fig"}). Lastly, 60 ± 1.7% of the gastrocnemius, 55 ± 1.16% of the rectus abdominis and 78 ± 1.16% of the myocardium total CB~1~ immunoparticles were localized to mitochondria and almost null in *CB*~*1*~-KO (Figure [2C](#F2){ref-type="fig"}), indicating that the predominant distribution of CB~1~ in the analyzed muscles is in this organelle.

Functional assays of mitochondrial CB~1~ in muscle
--------------------------------------------------

The regulation of mitochondrial bioenergetic functions by CB~1~ receptors was also investigated. Mitochondrial respiration was measured on heart mitochondria isolated from both wild-type and *CB*~*1*~-KO mice. The focus was on the myocardium because this muscle had the highest proportion of CB~1~ in the mitochondria. There was no difference between KO and wild-type isolated mitochondria regarding basal and coupled respiration (respectively State 4 and State 3; see Table [2](#T2){ref-type="table"}) and no difference was found regarding the respiratory coupling ratio (State3/State4). Together, these results showed that both wild-type and KO isolated mitochondria had the same capacity to produce ATP. Yet, acute THC treatment specifically inhibited mitochondrial oxygen consumption in wild-type isolated mitochondria. Adding 100 nM or 200 nM THC respectively decreased the mitochondria coupled respiration by 11.9 ± 3.7% and 15.2 ± 1.3% compared to the vehicle (*n* = 4) (Figure [3A](#F3){ref-type="fig"} left graph, *CB*~*1*~-WT; Figure [3B](#F3){ref-type="fig"}). In contrast, no significant difference was noticed between THC treated and vehicle in mitochondria isolated from *CB*~*1*~-KO heart (Figure [3A](#F3){ref-type="fig"} right graph, *CB*~*1*~-KO; Figure [3B](#F3){ref-type="fig"}). As a control, immunoprecipitation was performed to test for the presence of CB~1~ in the mitochondrial fractions. The protein extracts from *CB*~*1*~-WT and *CB*~*1*~-KO heart mitochondria fractions were subjected to immunoprecipitation with an antibody against CB~*1*~, and subsequently analyzed through Western blotting. Representative results demonstrate that CB~1~ was precipitated from the *CB*~*1*~-WT mitochondrial fraction but not from the *CB*~*1*~-KO fraction (Figure [3C](#F3){ref-type="fig"}).

###### 

**Basal (State 4) and coupled (State 3) respiration in isolated Mitochondria**.

  **OCR (nMol Oxygen/min/mg prot.)**   ***CB~1~*--WT**   ***CB~1~*--KO**
  ------------------------------------ ----------------- -----------------
  Pyruvate+Malate (State 4)            33.54 ± 4.03      38.52 ± 5.06
  Pyruvate+Malate+ADP (State 3)        122.08 ± 16.21    132.05 ± 16.24
  Coupling ratio                       3.75 ± 0.43       3.50 ± 0.26

Absolute value (means ± SEM, n = 6). Differences are non-significative.

![**(A)** Effect of THC on heart isolated mitochondria. THC (100 nM or 200 nM, gray bars) or vehicle (white bars) was added directly to the respiratory chamber during the ADP-dependent respiration. Values are expressed as mean of percentage of the ADP-dependent respiration of *CB*~*1*~-WT (left panel) or *CB*~*1*~-KO (right panel) isolated mitochondria (*n* = 4). **(B)** Difference of inhibition between vehicle and THC dependent respiration (White bars; *CB*~*1*~-WT, Black bars *CB*~*1*~-KO). ^\*^*P* \< 0.05 THC vs. VEH; ^\*\*^*P* \< 0.01 THC vs. VEH; ^\*\*\*^*P* \< 0.001 THC vs. VEH; \#*P* \< 0.05 *CB*~*1*~-WT vs. *CB*~*1*~-KO. C) Immunoprecipitation of CB~1~ from heart mitochondrial fractions of *CB*~*1*~-WT or *CB*~*1*~-KO.](fphys-07-00476-g0003){#F3}

Gene expression of relevant enzymes in pyruvate metabolism, TCA cycle and mitochondrial respiratory chain in the striated muscle
--------------------------------------------------------------------------------------------------------------------------------

To further investigate the mitochondrial energetic functions, the gene expression of key enzymes involved in pyruvate synthesis, TCA cycle and mitochondrial respiratory chain in the rectus abdominis of *CB*~*1*~-WT and *CB*~*1*~-KO mice was evaluated (Figure [4](#F4){ref-type="fig"}). *CB*~*1*~-KO mice showed an increase in the gene expression of *Eno3, Pkm2*, and *Pdha1* (^\*^*P* \< 0.05), suggesting an increased production of pyruvate, a main substrate of TCA cycle activity. In contrast, no significant difference was observed in the muscle expression of *Sdha* and *Cox4i1* between *CB*~*1*~-WT and *CB*~*1*~-KO mice (Figure [4](#F4){ref-type="fig"}).

![**Gene expression of *Eno3*, *Pkm2*, *Pdha1*, *Sdha* and *Cox4i1* in the striated muscle of *CB*~*1*~-WT and *CB*~*1*~-KO mice**. Student\'s *t*-test (*n* = 6): ^\*^*P* \< 0.05 vs. wild-type.](fphys-07-00476-g0004){#F4}

Discussion {#s4}
==========

Following our previous observations in rat and mouse (Arrabal et al., [@B4]) these data confirm and further extend the presence of CB~1~ in mitochondria of the mouse striated skeletal (gastrocnemius and rectus abdominis) and myocardial muscles. In particular, CB~1~ immunoparticles were localized on the outer mitochondrial membrane similarly to the mtCB~1~ distribution in the *CB*~*1*~-WT hippocampus, with almost absent mtCB~1~ in *CB*~*1*~-KO tissue (Bénard et al., [@B5]; Hebert-Chatelain et al., [@B19],[@B20]). Indeed, about 30% of the mitochondria in axon terminals and somatodendritic domains of neurons contained CB~1~ in the hippocampal CA1 region of *CB*~*1*~-WT, with a background of 3% in *CB*~1~-KO (Bénard et al., [@B5]). Although mtCB1 labeling has been challenged by using the DAB-Ni technique (Morozov et al., [@B37], [@B38], [@B39]) that produces a higher background mitochondrial staining than the immunogold procedure due to the presence of endogenous biotinylated proteins (Hollinshead et al., [@B24]; Bénard et al., [@B5]; Hebert-Chatelain et al., [@B19],[@B20]), careful quantifications revealed a significantly higher staining of brain mitochondria in wild-type than in *CB*~*1*~-KO brain tissue, regardless of the method used (Bénard et al., [@B5]; Hebert-Chatelain et al., [@B19],[@B20]). Furthermore, with a very restrictive quantification protocol, i.e., taking into account only mitochondrial particles far away from other neuronal membranes, about 22% of the mitochondrial sections were CB~1~ immunopositive in *CB*~*1*~-WT and only 3% exhibited particles in the *CB*~*1*~-KO hippocampal tissue (Hebert-Chatelain et al., [@B19],[@B20]).

The amount of mitochondria in striated muscles is more abundant than in the brain because the energy demand in muscle cells and cardiomyocytes is very high. Furthermore, the size, shape and number of mitochondria are constantly changing as a consequence of muscle and heart activity. Therefore, the distribution of CB~1~ receptors may depend on the quantity of muscle mitochondria. The results of this study showed that the proportion of mitochondrial sections equipped with CB~1~ in the muscle was in the range of the brain, indicating that only a certain subpopulation of mitochondria bearing CB~1~ receptors is present in both the CNS and the peripheral striated muscles. Furthermore, the immunolabeling density in the CA1 hippocampus was around 18 particles/μm^2^ and around 15% of the total CB~1~ immunolabeling in CA1 neurons was localized in the mitochondria (Bénard et al., [@B5]). In muscles, the density was only low in myocardium and the proportion of the total CB~1~ immunoparticles in the mitochondria was between 55 and 78% in the three muscle samples studied, pointing out that despite its low absolute level of expression in the myocardium, but not in the others (Pagotto et al., [@B40]), the majority of CB~1~ receptors in the muscle is present on mitochondrial membranes. In the brain, the activation of mtCB~1~ receptors induces a reduction of mitochondrial respiration of about 20--30% (Bénard et al., [@B5]; Hebert-Chatelain et al., [@B19],[@B20]). Similarly, THC activation of the CB~1~ receptors in the myocardium mitochondria reduces mitochondrial respiration, although at a lower rate than in the brain. This difference may be explained, among other factors, by the lower amount of CB~1~ receptors (particle density and percentage of positive mitochondria) in the myocardium as compared to the brain, which cannot be compensated by the fact that the vast majority of the total CB~1~ immunoparticles in myocardium are localized in mitochondria.

The two skeletal muscles analyzed, the gastrocnemius and the rectus abdominis, are enriched in type I slow-twitch oxidative fibers (Hijikata et al., [@B22]). Therefore, a potential role for mtCB~1~ receptors might be the regulation of the oxidative activity at the mitochondria, probably through the relevant enzymes Eno3 and Pkm2, which are implicated in the pyruvate metabolism (a main substrate for TCA cycle), as well as the Pdha and DLD, which are key components of the mitochondrial pyruvate/α-ketoglutarate/branched-chain keto acid (BCKDC) dehydrogenase complexes implicated in the TCA cycle activity (Arrabal et al., [@B4]). In fact, studies using a CB~1~ receptor antagonist (Rimonabant) demonstrated that a blockade of cannabinoid receptors increases glucose use by striated muscle (Liu et al., [@B31]; Cavuoto et al., [@B8]). Moreover, a previous study indicated that it is mandatory the abetment of a hypercaloric context and a deficiency in CB~1~ receptor activity to observe an increased expression of the mitochondrial respiratory chain component *Cox4i1* and a potential mitochondrial respiration (Arrabal et al., [@B4]). Together these results indicated an up-regulation of the glucose/pyruvate metabolism in response to increased energy expenditure through mitochondrial oxidation and TCA cycle in the insulin-highly sensitive striated muscle. However, the transcriptional differences in pyruvate metabolism could not reflect changes in the maximal capacity of ATP production, suggesting no evident differences in the basal phenotype of the *CB*~*1*~-KO muscle at functional levels. Indeed, we have not found any change in the gene expression of the mitochondrial respiratory chain factors *Sdha* (complex II) and *Cox4i1* (complex IV) or in the mitochondrial oxygen consumption rate between genotypes. Considering these findings, we suggest that the increased redox activity after CB~1~ receptor blockade (Arrabal et al., [@B4]) is likely produced in response to buffer a putative increase in reactive oxygen species. A buffered redox state under basal conditions could be one of the reasons for the lack of differences in mitochondrial respiration between genotypes, but can be challenged under an energy imbalance.

As the functional significance, the activation of CB~1~ receptors localized in different body tissues (brain, liver, skeletal muscle, pancreas, adipose tissue) participates in cellular and metabolic functions of the organism (Piomelli, [@B42]; Silvestri and Di Marzo, [@B48]; Iannotti et al., [@B25]; Mazier et al., [@B35]; Palomba et al., [@B41]) and regulates the mitochondrial biogenesis in non-neuronal peripheral tissues (Aquila et al., [@B3]; Tedesco et al., [@B52]). There are pieces of evidence indicating that mitochondria contain G proteins (Lyssand and Bajjalieh, [@B32]; Andreeva et al., [@B2]) and their effector signaling molecules such as soluble adenyl cyclase (Zippin et al., [@B53]), phosphodiesterase (Acin-Perez et al., [@B1]) and protein kinase A (PKA) (Ryu et al., [@B46]). Hence, cAMP generated in the mitochondria would lead to PKA activation and protein phosphorylation, thus regulating mitochondrial respiration and energy production (Chen et al., [@B10]; Helling et al., [@B21]; Acin-Perez et al., [@B1]). The oxidative phosphorylation carried out in mitochondria transforms the energy of the nutrients into ATP. The mitochondria regulate important physiological processes constantly adapting structure and functions to maintain the cellular metabolic homeostasis. In fact, mitochondria dysfunction is involved in neurodegenerative diseases obesity, insulin resistance and type 2 diabetes (Højlund et al., [@B23]; Bournat and Brown, [@B6]; Sivitz and Yorek, [@B49]; Dietrich et al., [@B12]; Schneeberger et al., [@B47]).

The skeletal muscle is the primary organ for nutrients and fatty acids oxidation, as well as glucose uptake. Insulin resistance is associated with a loss of muscular oxidative capacity in response to an increase of intake of fat-rich foods (Cavuoto et al., [@B8]). The insulin resistance plays an important role in the pathogenesis of the metabolic syndrome and type 2 diabetes (Kelley et al., [@B28]; Kelley, [@B27]), while the blocking of CB~1~ receptors in the skeletal muscle has a direct effect on energy expenditure and oxidative metabolism (Ravinet Trillou et al., [@B44]; Liu et al., [@B31]; Arrabal et al., [@B4]). Skeletal muscle cells have been shown to contain CB~1~ and CB~2~ receptors as well as the endocannabinoid enzymatic machinery (DAGLα, DAGLβ, and MAGL) (Crespillo et al., [@B11]), and also the localization of CB~1~ receptors in striated muscle mitochondria was identified (Arrabal et al., [@B4]). These observations altogether support an endocannabinoid regulation of genes controlling the skeletal muscle metabolism (Crespillo et al., [@B11]). Therefore, it is presumable that the opposite effects of endocannabinoids and CB~1~ agonists reducing mitochondrial function in metabolically active tissues (Tedesco et al., [@B52]), and of CB~1~ antagonism (Tedesco et al., [@B51]), are through CB~1~ receptors in the mitochondria.

In conclusion, CB~1~ receptors are localized in the mitochondria of striated muscles in a similar proportion to brain tissue. Interestingly, most of the CB~1~ receptors in the gastrocnemius, the rectus abdominis and the myocardium are distributed in the mitochondria, in contrast to the brain where they are preferentially localized in neuronal membranes (Freund et al., [@B16]; Kano, [@B26]; Di Marzo et al., [@B13]). Furthermore, the activation of the mitochondrial CB~1~ receptors in striated muscle may participate in the regulation of the oxidative activity at the muscle mitochondria probably through the relevant enzymes implicated in the pyruvate metabolism, a main substrate for the Krebs cycle activity.
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2-AG

:   2-arachidonoylglycerol

ATP

:   adenosine triphosphate

BSA

:   bovine serum albumin

cAMP

:   cyclic adenosine monophosphate

CB~1~

:   cannabinoid type 1 receptor

*CB*~*1*~-KO

:   lack of cannabinoid type 1 receptor

CNS

:   central nervous system

DAGLα, DAGLβ

:   diacylglycerol lipase α, β

Δ^9^-THC

:   delta-9-tetrahydrocannabinol

MAGL

:   monoacylglycerol lipase

mtCB~1~

:   mitochondrial cannabinoid type 1 receptor

OCR

:   oxygen consumption ratio

OsO4

:   osmium tetroxide

PB

:   phosphate buffer

PBS

:   phosphate-buffered saline

PKA

:   protein kinase A

qRT-PCR

:   quantitative reverse transcription polymerase chain reaction

RCR

:   respiratory coupling ratio

RT

:   room temperature

TBS

:   Tris-HCl buffered saline

WT

:   wild type.
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